Goldberg
Law PC (www.Goldberglawpc.com)
announces an ongoing investigation of potential misrepresentations by Insulet
Corporation (“Insulet” or the “Company”) (NASDAQ: PODD)
between February 27, 2013 and April 30, 2015, inclusive (the “Class
Period”). The investigation focuses on whether the Company and its
officers violated securities laws by allegedly concealing material
information from investors. The complaint was filed in the United States
District Court, District of Massachusetts, and the lead plaintiff
deadline is July 6, 2015.
If you purchased or otherwise acquired Insulet shares and would like
more information regarding the investigation, we advise you to contact Michael
Goldberg or Brian Schall,
of Goldberg Law PC, 13650 Marina Pointe Dr. Suite 1404, Marina Del Rey,
CA 90292, at 800-977-7401, to discuss your rights without cost to you.
You can also reach us through the firm’s website at http://www.Goldberglawpc.com,
or by email at info@goldberglawpc.com.
Insulet is a medical device corporation that manufactures the OmniPod
Insulin Management System, an insulin system for patients with
insulin-dependent diabetes. The complaint alleges that during the class
period Insulet made false and/or misleading statements and/or failed to
disclose that: (1) the Company was experiencing weaker demand for its
products; (2) the Company was having problems related to its sales and
marketing efforts; (3) as a result, the Company experienced unevenness
in its financial performance; and (4) as a result of the foregoing,
Insulets’ positive statements about the Company’s business, prospects,
and operations lacked a reasonable basis. On May 1, 2015, shares fell
almost 10% as a result of Insulet’s disappointing first quarter results.
If you have any questions concerning your legal rights in this case,
please immediately contact Goldberg Law PC at 800-977-7401, or visit our
website at http://www.Goldberglawpc.com,
or email us at info@goldberglawpc.com.
Goldberg Law PC represents shareholders around the world and specializes
in securities class actions and shareholder rights litigation.
This press release may be considered Attorney Advertising in some
jurisdictions under the applicable law and ethical rules.
View source version on businesswire.com: http://www.businesswire.com/news/home/20150701006485/en/
Copyright Business Wire 2015